drugset / Trial / NCT02391142
Clinical Assessment of the Treatment With Cardiac Sympathetic Blockade on Chronic Heart Failure
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effect of Cardiac Sympathetic Blockade on Mortality, re-hospitalization rate, symptoms, quality of life, exercise tolerance, cardiac structure, systolic function, electrical activities and concentration of B - type natriuretic peptide precursor in patients with Chronic Heart Failure.
Timeline
- Start
- 2014-06
- Primary completion
- 2018-12
- Completion
- 2019-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 0.5 % | Other |
| Subject | Lidocaine | Other / unclassified | 5 ml | Other |
| Subject | Ropivacaine | Other / unclassified | 0.2 % | Other |
| Subject | Ropivacaine | Other / unclassified | 5 ml | Other |